About Epicore Biosystems
Epicore Biosystems is a company based in Cambridge (United States) founded in 2017 by Stephen Lee, Jeff Model, Alexander J Aranyosi, and Roozbeh Ghaffari. Epicore Biosystems has raised $43.89 million across 7 funding rounds from investors including Chevron, HHS and Denka. Epicore Biosystems offers products and services including Biowearables, Gx Sweat Patch, and Sweat Analysis System. Epicore Biosystems operates in a competitive market with competitors including Polar, Nix, Mode Sensors, Healbe and Bitome, among others.
- Headquarter Cambridge, United States
- Founders Stephen Lee, Jeff Model, Alexander J Aranyosi, Roozbeh Ghaffari
-
Sectors
TechnologyHealthcare Media & Entertainment
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epicore Biosystems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$43.89 M (USD)
in 7 rounds
-
Latest Funding Round
$6 M (USD), Series B
May 01, 2025
-
Investors
Chevron
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epicore Biosystems
Epicore Biosystems offers a comprehensive portfolio of products and services, including Biowearables, Gx Sweat Patch, and Sweat Analysis System.
Devices for analyzing sweat to track hydration and biomarkers.
Patch that monitors sweat for electrolyte losses in sports.
System for non-invasive biomarker collection in research.
People of Epicore Biosystems
Unlock access to complete
Unlock access to complete
Funding Insights of Epicore Biosystems
Epicore Biosystems has successfully raised a total of $43.89M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $6 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epicore Biosystems
Epicore Biosystems has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Chevron, HHS and Denka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing and portfolio management services for accredited investors.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on tech sectors
|
Locked | Locked | Locked | |
|
Venture capital fund investing in tech startups
|
Locked | Locked | Locked |
Investor details for Epicore Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epicore Biosystems
Investment portfolio details for Epicore Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epicore Biosystems
Detailed financials for Epicore Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epicore Biosystems Comparisons
Peer comparison for Epicore Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epicore Biosystems
Epicore Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polar, Nix, Mode Sensors, Healbe and Bitome, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smart sports watches for fitness tracking are provided.
|
|
| Locked | Locked | Locked |
Sweat-based biosensors are provided for body hydration monitoring.
|
|
| Locked | Locked | Locked |
Provider of hydration monitoring patch
|
|
| Locked | Locked | Locked |
Wristband with noninvasive glucose monitor and calorie tracker.
|
|
| Locked | Locked | Locked |
Wearable device that tracks hydration levels
|
Detailed competitors of Epicore Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epicore Biosystems
Complete news archive for Epicore Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epicore Biosystems
Epicore Biosystems was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Epicore Biosystems is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Roozbeh Ghaffari is the current CEO of Epicore Biosystems. They have also founded this company.
Epicore Biosystems is a funded company, having raised a total of $43.89M across 7 funding rounds to date.
Epicore Biosystems was founded in 2017 in Cambridge, United States, within the biotech and wearables sector. A proprietary sweat microfluidic sensing platform, designed to be skin-like, is offered for analyzing small sweat droplets directly from the skin. Real-time data visualization is enabled through a companion mobile application. Applications span sports teams, military research labs, and clinical studies, with operations focused on sensor development and integration.
Epicore Biosystems's top competitors include Nix, Polar and Mode Sensors.
Epicore Biosystems offers Biowearables, Gx Sweat Patch, and Sweat Analysis System.
Epicore Biosystems has 7 investors. Key investors include Chevron, HHS, Denka, Alumni Ventures, and Joyance Partners.